Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Penumbra, Inc. PEN NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
67/100
3/7 Pass
SharesGrow Intrinsic Value
$304.88
-8.3%
Analyst Price Target
$371.92
+11.9%

Balance sheet is a point-in-time snapshot. TTM shows the most recent available quarter.

Metric Latest Quarter (2025-12)
Total Assets $1.83B
Total Liabilities $398.92M
Total Debt $219.7M
Cash & Investments $186.9M
Total Stockholders Equity $1.43B

People Also View

DXCM
DXCM
DexCom, Inc.
$61.54
-2.24%
 PODD
PODD
Insulet Corporation
$202.50
+0.50%
 ALGN
ALGN
Align Technology, Inc.
$186.53
+1.00%
 GMED
GMED
Globus Medical, Inc.
$94.55
-0.41%
 SWAV
SWAV
ShockWave Medical, Inc.
$334.75
-0.02%
 DVA
DVA
DaVita Inc.
$144.57
-3.27%
 MASI
MASI
Masimo Corporation
$178.39
+0.03%
 BAX
BAX
Baxter International Inc.
$17.60
+0.06%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message